A critical review of the efficacy of meprobamate (Miltown, Equanil) in the treatment of anxiety
- 1 June 1958
- journal article
- review article
- Published by Elsevier in Journal of Chronic Diseases
- Vol. 7 (6), 500-519
- https://doi.org/10.1016/0021-9681(58)90168-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- MEPROBAMATE—A CLINICAL STUDYAmerican Journal of Psychiatry, 1957
- USE OF A "DOUBLE-BLIND" STUDY INVESTIGATING THE CLINICAL MERITS OF A NEW TRANQUILIZING AGENTAnnals of Internal Medicine, 1957
- Use of Meprobamate in Tension StatesJournal of Mental Science, 1957
- TREATMENT OF ANXIETY STATES WITH MEPROBAMATEAnnals of the New York Academy of Sciences, 1957
- MEPROBAMATE, A CLINICAL EVALUATIONAnnals of the New York Academy of Sciences, 1957
- Controlled Trial of MeprobamateBMJ, 1956
- CLINICAL STUDY OF A NEW TRANQUILIZING DRUGJAMA, 1955
- STUDY OF EFFECT OF MILTOWN (2-METHYL-2-N-PROPYL-1,3-PROPANEDIOL DICARBAMATE) ON PSYCHIATRIC STATESJAMA, 1955
- The controlled clinical trial: Theory and practiceJournal of Chronic Diseases, 1955
- The use and misuse of the chi-square test.Psychological Bulletin, 1949